Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks to those who shared the post CC replay info. ..and who answered my question about the 10-K filing. Most importantly, the CEO is transparent and keeping us abreast of developments (better than most CEO's). For those who are careless with stock price forecasting and expecting a huge Partnership today (keep your expectations more realistic).
We have an incredible opportunity here to invest in a potential blockbuster...and growth takes time. I am very pleased with past, current and future prospects (so many catalysts that could drive shareholder value).
I am glad many here are posting real time information ..related to the Conference Call (I could not participate or listen in to it).
I would like to know...was there any mention about the upcoming 10-K filing and what they did exactly to increase the O/S base recently? Thx.
Well said: the Portfolio here is substantial...so many possibilities here for Licensing, Partnering, JV's opportunities.
What a powerful technology with MANF too (I only wonder how many Pharma's are salivating with the possibility of acquiring this company). Lastly, the Diagnostic business is going to be very HUGE.....I cant wait to here about the timelines and potential for commercialization (in next weeks conference call).
LIFESCI:
If the latter is so; the expectations are very high here. I will need to see sustained volume and incremental movement higher to validate that reality.
I like what I see in Mgt. (very savvy decision making) and the transparency here (is as good as any company in the investment universe).
I am really looking forward to the Conference call update next week.
My favorite question to ask: What did Gerald do exactly by issuing more shares.....?
a) purchase another drug to compliment MANF.
b) just issued the shares to compensate BOD, Advisory board and Mgt.
c) did some type of In-Licensing deal with a 3rd party (Diagnostics business).
d)JV deal with a 3rd party (Pharma); had to pay investment bankers, Lawyers, etc.
e)Pay off to vendors who threatened lawsuits over lack of payments.
Speculation is fun!! Fridays trading was simply a massive short covering or just the beginning a substantial rally to adjust our market capitalization ....for something HUGE on the horizon.
GLTA!!!
Dr. Jerry:
Thanks for your continued support and sharing extremely important info:
1) AMEX listing? Is that just a hunch or any specific reason as to why you are speculating an AMEX listing?
2) I believe the A/H news suggested that LymPro Phase 2 was about to start; I thought things were in motion already with Phase 2?
Thanks for your thoughts and feedback.
Outstanding work Gerald!!! The current structure and foundation can be highly leveraged into a very successful biotech company. Todays news was spectacular; I dont know how many clues are needed for investors to read the writing on the wall.
Fridays have been very good days for AMBS; I expect tomorrow just might be a banner day. GLTA!!!
What a difference a day makes....you have a powerhouse in the making folks. I will agree with several posters here today. MANF is in the backseat; the Diagnostics side of the business is going to be a HUGE winner here. Once Wall Street understands and realizes that this company is going to be commercialized sooner than later...its off to the races. GLTA!!!
I would agree that the Market cap should be over $50mm today. I was wondering if the incremental increase in the O/S could include Restricted stock (maybe the Float will be much smaller than people think).
Overall, I just think many here need to still believe in the Science (and who they have recruited to their respect B.O.D and Advisory board). Its no secret; the Dilution really stinks...knew their would be some but not over a 100mm increase (that was very disappointing).
Lastly, the fact that this message board has decreased in volume significantly ..tells me that the strong will stick this out (and the weak (or those who wanted to make a fortune overnight probably learned a valuable lesson and parted ways).
Any experts who can break down whats going on here...somewhat confusing to me.
B. Amarantus Nevada was incorporated on March 22, 2013. Its authorized capital stock consists of: (1) 1,000,000,000 shares of Common Stock, with a par value of $0.001 per share (“Amarantus Bioscience, Inc. Nevada Common Stock”), of which, pursuant to the terms of this Agreement and Plan of Merger, 367,790,139 shares will be issued and outstanding at the Effective Time (as defined below); and (2) 10,000,000 shares of Preferred Stock, $0.001 par value (“Amarantus Bioscience, Inc. Nevada Preferred Stock”), of which, pursuant to the terms of this Agreement and Plan of Merger, 250,000 shares are issued and outstanding at the Effective Time.
We will get some major upside catalysts (at some point); but the upside will be more constrained...lets hope at least we bottomed out for now.
Ouch!! We just got the reason for the PPS tanking. I really dont understand the need to heavily dilute anymore...Ridiculous!!!
Markets are closed on Friday; so make it two more days (He will come through). The key question is whether preclinical data will move us back higher (I would say back above $.06 and maybe $.07.
He will need to add something more dynamic as to next steps (with MANF) to entice the market buyers to step up and be aggressive.
Dilutive financing is always possible; there are no guarantees. But the Science could make our PPS go up 20 fold over the next few years (its worth the risk).
They will need money; but as someone here has posted....Gerald has repeatedly turned down some Venture capital $$ and other investment offers. They Science is too rich here; they will have options and are in more control of there future (than you can think).
Dilution can (and probably will occur...lets hope its modest in nature). I really am surprised how short sighted so many are here....these investments are like a fine wine (they need time to mature).
I am looking forward to this coming week. The Swiss audited results will happen (or at least should) and our PPS is right at (or very near the bottom). The MM's could push us down (intraday) one last time to shake out some more weak holders (or trigger some limit orders).
I like all the things that are happening (quietly); so many good things to come (Gerald has made some very respectable moves with cleaning up the Balance sheet, getting the right talent on the BOD and Advisory board, attending Conferences, lining up some additional funding, etc.
Lastly, we have a very strong bunch of core holders (its quite obvious based on these posts). The best time to buy is when their is blood running in the streets....have faith and realize that the upside is massive here).
GLTA!!!
My friend...I will tend to disagree. The audited findings will present enormous confidence to those deeply interested investors. Do you really think that management voluntarily decided to do this..or that their is a savvy Wall street investor, Pharma or JV partner who requested that this reality get done (before they decide to invest a substantial position or provide much needed funding).
I am betting on the latter....I expect an increase in our PPS; but it wont be over a $.05 or $.10 (perhaps $.02 or $.03...but thats a start in the right direction). Babysteps......the big news is still weeks/months away.
The weak holders here are sweating bullets (for one reason or another). My take; the market has been quietly selling off (Dow is propped up to mask the selling pressure). Translation: the risk trade is somewhat unwinding; therefore...stock like AMBS will have momentum selling as the market trends lower,
Fundamentally, the company is rock solid (maybe some modest dilution will occur). The Science is all that matters folks...our audited MANF data is coming shortly (should move us up and off these levels). GLTA!!
We are once again ascending ....the MANF results will be confirmed by the Swiss company and reported over the next week (or two). I expect continued accumulation and price advancement heading into that news. Also, Wall Street definitely took notice to the new BOD director (this guy has some outstanding connections).
Our journey continues....and we havent had any materials news for the most part (we will gap up some day soon.....). GLTA!!
We are finally getting some true underlying buying and support at $.065 (some serious volume is supporting our PPS). We are getting much closer to material news; I am guessing that it will be next week (may see some news this week...but I mean something that moves up back up over $.08 or $.10).
GLTA!!
When the 10Q is updated (and it will be shortly) ...you will get your answers regarding O/S. If I was a long term shareholder; my focus would be on whats going on with the Science surrounding MANF and the Diagnostic portfolio.
Based on the dialect on this board; I think their might be more pain ahead (in price action); as we have not flushed out enough WEAK holders yet (focus is on the wrong things).
Bottom line: you are talking about a company that has multi billion revenue potential (stop worrying about 230mm vs 275mm O/S). Moreover, you have to look at the history of Amgen and where it trades today (to see the potential in AMBS).
PATIENCE!!!!!
Typically, Fridays have been good days to us; lets see if we can at least get back over $.07 and close to start next week right. GLTA!!
The Biotech sector is flat and has been selling off across the sector lately (including AMBS). Fundamentally, there is nothing wrong with our PPS whatsoever.
So many potential catalysts that could break us upward in a heartbeat; The strong will survive and make some coin when the tide turns......and it will.
Keep the faith....your reward is around the corner.
Next big catalyst:
Swiss company to validate MANF research findings ...and company to validate and report results in late March. I am sure that a walkup will occur next week .....and into that news (could be Roche who is conducting the validation studies).
This is a very young company with a limited workforce....and with a very broad portfolio (and limited resources). MANF is a drug/technology that will blossom....cant rush it.
The Diagnostic portfolio has huge short to medium potential...I am looking forward to updates here soon. You need to just forget the day to day disappointment (in your words and world) and just look at it by a quarter to quarter comparison. We have more MANF updates due by the end of March (I felt the Seeking Alpha article fairly outlined the steps going forward ...this is not a get rich scheme overnight...so adjust your mentality and think longer term).
What is more important; that the CEO takes his precious time to respond to Retail investors or that he invests his time building a vast portfolio filled with very promising drugs and diagnostic products...moving us further to commercialization and revenue.
Wake up people....I am starting to appreciate that S/T investor patience is wearing thin...please move on somewhere else.
There has been way too much noise in this stock over the last several months. The recent slowdown in volume and trading is really does not surprise me at all. You just have to read this message board to know so many expect here to make an overnight windfall.
Each day; more and more are selling as they lost patience (just what the Market makers ideally want as they build their inventory.... gobbling up weak shares).
Overall, The PPS has a very bright future; just be patient and watch the fundamentals ...and its all about the Science too.
Stay long and strong........
Terminating the Rainbow deal was a very good decision. If you research and see the background of Rainbow; Amarantus is in a entirely different league now. The Advisors are doing what they were hired to do....make sound business decisions and build relationships with the right partners (not weak players).
So many good things to come....we are entering a very bullish phase...the quality of the PR's are going to move the stock price much more going forward.
Agree....Rainbow was a Florida based company with any rich history. I feel that something bigger is pending and brewing...as the timing of the termination was accelerated....so many good things to come.
Nice consolidation day after a decent % gain over the last two trading days. Weak hands will sell as the price moves up...as someone dont have the stomach to take another potential downturn ...and just want to get there money back.
The Diagnostics business (and future success) is going to drive our PPS higher...it will definitely be used as a bargaining chip to raise future cash. I expect licensing will be most important...to sell should only happen if the company cant get a partnership for MANF.
So many exciting things to come here....absolutely one of the most grossly under rated companies in the biotech space.
You are kidding me. Why does it really matter if the S8 was files after hours. It will have little affect on the stock price; it was a sound business decision. You have to know the history of the company; they are all working for peanuts.
Focus on the enormous potential on MANF and the near term commercialization potential for the Diagnostics portfolio (thats what its all about).
I strongly believe the TBI conference is really going to move the needle. I am expecting some type of significant announcement next week.
I am sure their will be some overhead resistance on the way back up...but I expect once it gets back above $.10....it will fly. Monday should be a really good day...but I will take a Friday (like today) any day of the week.
GLTA!!
Once we move up to more substantial news (the pre clinical stuff is meaningful...but it wont move the needle much); it will be much smoother skies.
Honestly, I am deeply focused on the Diagnostics side of the business; as any hint of near term commercialization (within one year) will really send our PPS soaring. I am surprised that their has been any re validation or progress updates with the Alzheimers or Parkinsons test kits lately.
Revenue and profits is whats its all about....I agree that March will be a HUGE month for PR's.
It is truly amazing just how many different directions this company can go.....we have not even heard of what Orphan indications that are appropriate for MANF yet either.
In my humble opinion, I think Gerald timed the news in a fortunate way (as I am confident we might have hit the $.05+ range today without it...it was a really bad market day...along with the manipulation too).
The shorts are desperate to cover in a hurry...as more news is just around the corner. I expect multiple news releases every week because their portfolio is so vast...so many possibilities. GLTA!!!
Dr. Jerry:
If its true that NuroPro will be commercialized later this year...then this stock should be appreciating rather fast and significantly. Do you have any conclusive evidence that this is product is that far along and will be out selling on the market that quickly?
I really think that our PPS is only one significant PR release away from going to $.15-$.20 on an immediate basis (any JV, buyout...the sky is the limit).
Insider trading rules regulate when company management are privvy to material news...that's imminent. Therefore, they cant trade on that respective news or it will violate Insider trading rules.
If Amgen made an unsolicited offer tomorrow; its possible that Gerald would not have violated any Insider trading rules because he did not know about the deal beforehand....so under these conditions...an buyout offer could come at anytime (of course...only if its unsolicited and not know to management).
My favorite quote: "Hold for the Gold"
March will be a big month for PR's; MM's suppressing bullish reality to clean out weak holders in advance of many quality PR's on they way....and when this moves up it will do so in a hurry.
I put my money where my mouth was...and added $200k over the last two days. Buy when there is blood in the streets...our CEO has done that exactly. And so should you.......
Its a new day.......its all about the fundamentals. GLTA!!!
Per the Chairmans blog released today; the Diagnostics portfolio will be the key S/T drivers (to move the stock price up) going forward. The LymPro asset is far along regarding testing for Alzheimers. Also, Gerald has clearly indicated that more news is coming in the very near future.....continue to hold or accumulate to dollar cost average....so many good things on the way (it closer than you think).
Per Gerald today:
"We are currently working on updating the clinical trial design for the LymPro and NuroPro assets in light of recent developments in the field and will update the marketplace in the near future regarding timelines to key milestones on their path to commercialization. At that time, we will also address how our shareholders will benefit from the spinoff".
Nice post!!! A great reality check to those who fail to understand and realize how much potential this company really has.....Long and strong here.